Zurcher Kantonalbank (Zurich Cantonalbank) Apellis Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 19,212 shares of APLS stock, worth $636,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,212

Previous 19,212 -0.0%

Holding current value

$636,685

Previous $554,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$28.84 - $41.15 $11,593 - $16,542	-402 Reduced 2.05%	19,212 $554,000
Q2 2024 Jul 29, 2024	BUY	$38.07 - $59.71 $100,314 - $157,335	2,635 Added 15.52%	19,614 $752,000
Q1 2024 Apr 25, 2024	SELL	$55.39 - $72.47 $174,146 - $227,845	-3,144 Reduced 15.62%	16,979 $998,000
Q4 2023 Jan 30, 2024	BUY	$37.14 - $64.82 $226,628 - $395,531	6,102 Added 43.52%	20,123 $1.2 Million
Q3 2023 Oct 25, 2023	BUY	$23.65 - $89.22 $30,981 - $116,878	1,310 Added 10.31%	14,021 $533,000
Q2 2023 Aug 07, 2023	BUY	$76.68 - $93.31 $80,514 - $97,975	1,050 Added 9.0%	12,711 $1.16 Million
Q1 2023 May 08, 2023	BUY	$46.59 - $66.96 $47,801 - $68,700	1,026 Added 9.65%	11,661 $769,000
Q4 2022 Feb 01, 2023	SELL	$43.24 - $61.04 $38,051 - $53,715	-880 Reduced 7.64%	10,635 $549,000
Q3 2022 Nov 09, 2022	BUY	$44.76 - $69.66 $49,549 - $77,113	1,107 Added 10.64%	11,515 $786,000
Q2 2022 Aug 09, 2022	SELL	$35.07 - $59.21 $42,750 - $72,176	-1,219 Reduced 10.48%	10,408 $471,000
Q1 2022 Apr 21, 2022	SELL	$35.46 - $54.12 $72,409 - $110,513	-2,042 Reduced 14.94%	11,627 $591,000
Q4 2021 Feb 01, 2022	BUY	$30.74 - $49.16 $195,291 - $312,313	6,353 Added 86.84%	13,669 $646,000
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $408 - $907	13 Added 0.18%	7,316 $241,000
Q2 2021 Jul 30, 2021	BUY	$40.9 - $64.9 $3,353 - $5,321	82 Added 1.14%	7,303 $462,000
Q1 2021 May 03, 2021	SELL	$40.8 - $57.39 $36,924 - $51,937	-905 Reduced 11.14%	7,221 $310,000
Q2 2020 Jul 28, 2020	BUY	$24.8 - $38.49 $83,948 - $130,288	3,385 Added 71.4%	8,126 $265,000
Q1 2020 May 06, 2020	BUY	$17.91 - $44.33 $12,537 - $31,031	700 Added 17.32%	4,741 $127,000
Q4 2019 Jan 21, 2020	BUY	$22.1 - $30.8 $36,619 - $51,035	1,657 Added 69.51%	4,041 $124,000
Q3 2019 Oct 18, 2019	SELL	$24.09 - $32.18 $13,490 - $18,020	-560 Reduced 19.02%	2,384 $57,000
Q2 2019 Jul 30, 2019	BUY	$18.0 - $25.34 $19,782 - $27,848	1,099 Added 59.57%	2,944 $75,000
Q1 2019 Apr 29, 2019	SELL	$12.81 - $19.82 $13,552 - $20,969	-1,058 Reduced 36.45%	1,845 $36,000
Q4 2018 Jan 25, 2019	BUY	$11.47 - $18.71 $20,473 - $33,397	1,785 Added 159.66%	2,903 $38,000
Q3 2018 Nov 09, 2018	BUY	$16.57 - $21.03 $18,525 - $23,511	1,118 New	1,118 $20,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Apellis Pharmaceuticals, Inc. Transaction History